It may be of interest to you and other Gumshoe members regarding a new spray formulation for Covid 19 being developed by Starphama Holdings which has some unique and impressive results versus Remdesivir sensitivities and other antiviral indications. They were just awarded a million dollars by the Australian Government to assist in the development of the drugs commercialization prospects.
I have owned this companies stock for a few years due to their dendrimer product used in other indications. Thanks for all the in depth info you provide on other promoted stocks. Keith Nelson
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.